We are live on ! Find out more
PA

Parallel Advisors Portfolio holdings

AUM $6.56B
1-Year Est. Return 32.24%
This Fund
S&P 500
This Quarter Est. Return
-0.84%
1 Year Est. Return
+32.24%
3 Year Est. Return
+108.68%
5 Year Est. Return
+114.4%
10 Year Est. Return
AUM
$2.48B
AUM Growth
+$119M
Cap. Flow
+$156M
Cap. Flow %
6.28%
Top 10 Hldgs %
35.06%
Holding
3,425
New
363
Increased
1,606
Reduced
626
Closed
191

Sector Composition

Rank Sector Weight
1 Technology 15.89%
2 Financials 8.07%
3 Healthcare 5.89%
4 Consumer Discretionary 5.37%
5 Communication Services 5.12%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BILI icon
1301
Bilibili
BILI
$7.95B
$46K ﹤0.01%
690
+184
+36% +$15.7K
LPLA icon
1302
LPL Financial
LPLA
$29.3B
$46K ﹤0.01%
296
+149
+101% +$21.4K
SASR
1303
DELISTED
Sandy Spring Bancorp Inc
SASR
$46K ﹤0.01%
1,001
+157
+19% +$6.72K
CYXT
1304
DELISTED
Cyxtera Technologies, Inc. Class A Common Stock
CYXT
$46K ﹤0.01%
+5,000
New +$46.8K
CPB icon
1305
Campbell Soup
CPB
$6.69B
$45K ﹤0.01%
1,066
+205
+24% +$8.9K
FIVN icon
1306
FIVE9
FIVN
$2.58B
$45K ﹤0.01%
284
+116
+69% +$21.2K
LAB icon
1307
Standard BioTools
LAB
$309M
$45K ﹤0.01%
6,895
MSTR icon
1308
Strategy Inc
MSTR
$37.4B
$45K ﹤0.01%
780
+20
+3% +$1.28K
SAIA icon
1309
Saia
SAIA
$9.5B
$45K ﹤0.01%
191
+10
+6% +$2.31K
VIPS icon
1310
Vipshop
VIPS
$7.4B
$45K ﹤0.01%
4,048
+190
+5% +$2.99K
LSXMK
1311
DELISTED
Liberty Media Corporation Series C Liberty SiriusXM Common Stock
LSXMK
$45K ﹤0.01%
1,228
+318
+35% +$11.7K
ZNH
1312
DELISTED
China Southern Airlines Company Limited
ZNH
$45K ﹤0.01%
1,600
+600
+60% +$16.9K
VER
1313
DELISTED
VEREIT, Inc.
VER
$45K ﹤0.01%
984
+6
+0.6% +$291
CRH icon
1314
CRH
CRH
$67B
$44K ﹤0.01%
934
-153
-14% -$7.75K
KOF icon
1315
Coca-Cola Femsa
KOF
$22.9B
$44K ﹤0.01%
785
+160
+26% +$8.96K
NBIX icon
1316
Neurocrine Biosciences
NBIX
$16.8B
$44K ﹤0.01%
463
+261
+129% +$24.7K
PK icon
1317
Park Hotels & Resorts
PK
$2.92B
$44K ﹤0.01%
2,309
+93
+4% +$1.76K
NTCO
1318
DELISTED
Natura &Co Holding S.A. American Depositary Shares (each representing two Common Shares)
NTCO
$44K ﹤0.01%
2,648
-262
-9% -$5.36K
ARKG icon
1319
ARK Genomic Revolution ETF
ARKG
$1.78B
$43K ﹤0.01%
574
-501
-47% -$42K
BCS icon
1320
Barclays
BCS
$94.3B
$43K ﹤0.01%
4,168
+1,373
+49% +$13.7K
ENTA icon
1321
Enanta Pharmaceuticals
ENTA
$401M
$43K ﹤0.01%
765
+667
+681% +$33K
JBLU icon
1322
JetBlue
JBLU
$2.13B
$43K ﹤0.01%
2,841
+862
+44% +$13.2K
JWN
1323
DELISTED
Nordstrom
JWN
$43K ﹤0.01%
1,612
+157
+11% +$5.01K
MHK icon
1324
Mohawk Industries
MHK
$9.19B
$43K ﹤0.01%
240
+3
+1% +$581
ST icon
1325
Sensata Technologies
ST
$6.67B
$43K ﹤0.01%
784
+337
+75% +$19.4K

Similar funds

Parallel Advisors's Q3 2021 Portfolio in Review

As of Q3 2021, Parallel Advisors held 3,425 positions worth $2.48B, up 5% from $2.36B the previous quarter. Its ten largest holdings account for 35% of the portfolio.

Parallel Advisors deployed $156M of net new capital in Q3 2021, opening 363 new positions and adding to 1,606 existing holdings. Its largest new stake was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.

By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 16% a quarter earlier, followed by Financials and Healthcare.

On the sell side, the largest reduction was iShares US Medical Devices ETF, an estimated $15.9M trimmed.

  • Parallel Advisors's largest Q3 2021 buy was iShares ESG Aware 1-5 Year USD Corporate Bond ETF: 13,650 shares worth $355K.
  • Parallel Advisors added most to iShares Core MSCI EAFE ETF in Q3 2021, an estimated $24.8M increase.
  • Parallel Advisors's biggest Q3 2021 reduction was iShares US Medical Devices ETF, cutting an estimated $15.9M.
  • Parallel Advisors fully exited Slack Technologies, Inc. in Q3 2021, selling an estimated $1.71M.
  • Parallel Advisors's ten largest holdings make up 35% of its $2.48B portfolio in Q3 2021.
  • Parallel Advisors opened 363 new positions and closed 191 in Q3 2021.
  • Parallel Advisors's portfolio value rose 5% quarter-over-quarter to $2.48B.

Based on Parallel Advisors's 13F filing for Q3 2021, filed 22 Oct 2021.